Skip to main content

Closed

SKYE: Skye Bioscience, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-633.7%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage-26866.0×

Current ratio1.78×

Skye Bioscience, Inc.

SKYENASDAQ·USD·Closed

Skye Bioscience, Inc.

SKYENASDAQ·USD·Closed

$0.57

−2.03%

$0.57

−$0.01 (2.03%)

52W Range

0thpctl

Volume

1.04×avg

Mkt Cap

19.98MUSD

P/E

-0.4TTM

Div Yield

–ann

52W Range

0thpctl

Volume

1.04×avg

Market Cap

19.98MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings